Trigeminal neuralgia: An overview from pathophysiology to pharmacological treatments

E Gambeta, JG Chichorro, GW Zamponi - Molecular pain, 2020 - journals.sagepub.com
The trigeminal nerve (V) is the fifth and largest of all cranial nerves, and it is responsible for
detecting sensory stimuli that arise from the craniofacial area. The nerve is divided into three …

[HTML][HTML] Repetitive transcranial magnetic stimulation in central post-stroke pain: current status and future perspective

RS Radiansyah, DW Hadi - The Korean Journal of Pain, 2023 - synapse.koreamed.org
Central post-stroke pain (CPSP) is an incapacitating disorder that impacts a substantial
proportion of stroke survivors and can diminish their quality of life. Conventional therapies …

Safety and efficacy of a Nav1. 7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal …

JM Zakrzewska, J Palmer, V Morisset… - The Lancet …, 2017 - thelancet.com
Background Current standard of care for trigeminal neuralgia is treatment with the sodium
channel blockers carbamazepine and oxcarbazepine, which although effective are …

Inhibition of NMDA receptors through a membrane-to-channel path

MR Wilcox, A Nigam, NG Glasgow… - Nature …, 2022 - nature.com
N-methyl-d-aspartate receptors (NMDARs) are transmembrane proteins that are activated by
the neurotransmitter glutamate and are found at most excitatory vertebrate synapses …

[HTML][HTML] Carbamazepine, venlafaxine, tramadol, and their main metabolites: Toxicological effects on zebrafish embryos and larvae

P Rodrigues, L Guimarães, AP Carvalho… - Journal of Hazardous …, 2023 - Elsevier
Pharmaceutical compounds and their metabolites are found in natural and wastewater.
However, investigation of their toxic effects on aquatic animals has been neglected …

Small molecule targeting NaV1. 7 via inhibition of CRMP2-Ubc9 interaction reduces pain-related outcomes in a rodent osteoarthritic model

S Hestehave, HN Allen, K Gomez, P Duran… - Pain, 2025 - journals.lww.com
Osteoarthritis (OA) is a highly prevalent and disabling joint disease, characterized by
pathological progressive joint deformation and clinical symptoms of pain. Disease-modifying …

Pharmacotherapy for pain in a family with inherited erythromelalgia guided by genomic analysis and functional profiling

P Geha, Y Yang, M Estacion, BR Schulman… - JAMA …, 2016 - jamanetwork.com
Importance There is a need for more effective pharmacotherapy for chronic pain, including
pain in inherited erythromelalgia (IEM) in which gain-of-function mutations of sodium …

Pregabalin–tolperisone combination to treat neuropathic pain: Improved analgesia and reduced side effects in rats

N Essmat, AR Galambos, PP Lakatos, DÁ Karádi… - Pharmaceuticals, 2023 - mdpi.com
The current treatment of neuropathic pain (NP) is unsatisfactory; therefore, effective novel
agents or combination-based analgesic therapies are needed. Herein, oral tolperisone …

[HTML][HTML] Intracellular calcium homeostasis and its dysregulation underlying epileptic seizures

X Zhou, Z Chen, L Xiao, Y Zhong, Y Liu, J Wu, H Tao - Seizure, 2022 - Elsevier
Biological activities require a delicate balance between excitatory and inhibitory signals in
the brain. Disruption of this balance could lead to neurological disorders, such as …

Nanoparticle-based delivery of carbamazepine: A promising approach for the treatment of refractory epilepsy

A Zybina, A Anshakova, J Malinovskaya… - International journal of …, 2018 - Elsevier
Resistance to antiepileptic drugs (AEDs) is a major clinical problem. The overexpression of
P-glycoprotein (Pgp), one of the main transporters limiting the entry of xenobiotics into the …